Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
ADAR1 affects HCV infection by modulating innate immune response.
Positioning Europe for the EPITRANSCRIPTOMICS challenge.
SAMHD1 is active in cycling cells permissive to HIV-1 infection.
RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.
Highlights of the 30th International Conference on Antiviral Research.
Antiviral treatment strategies based on gene silencing and genome editing.
Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.
The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells.
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.